Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) announced today that it has entered into definitive subscription agreements with investors pursuant to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE